semaglutide injections birmingham Compounded Effective Weight Loss Solution Ozempic® & Wegovy® Weight-Loss Injections

When to Seek Medical Advice About Constipation Whilst constipation is a common and generally manageable side effect of GLP-1 therapy, certain symptoms warrant prompt medical evaluation

Your support helps me continue sharing everything Ive learned in the clinic with the world Prefer a one-off thank you

The STEP trials for semaglutide 2.4 mg (Wegovy) showed: Average weight loss of approximately 15% of body weight over 68 weeks One-third of participants lost 20% or more of body weight Significant reductions in waist circumference, blood pressure, and cardiovascular risk markers The SURMOUNT trials for tirzepatide (Zepbound) showed even more impressive results: Average weight loss of 20-25% at the highest dose (15 mg) over 72 weeks More than half of participants lost 20% or more of body weight Significant improvements in type 2 diabetes markers, blood pressure, and lipid profiles The head-to-head comparison is clear

Andrew Huberman And so I was always interested in the long arc of things